title: Prostaglandin synthesis by day-6 rabbit blastocysts in vitro.
abstract: Day-6 rabbit blastocysts were recovered from superovulated donor animals, washed in ice-cold Krebs-Ringer-bicarbonate (KRB) buffer, pooled and randomly allocated to polypropylene incubation tubes, usually 10 blastocysts in 1 ml KRB. The blastocysts were ruptured with a dissecting needle and incubated at 37 degrees C for periods of 1-3 h with 10 microCi [3H]arachidonic acid/tube. A control tube without blastocysts was run in each experiment. At the end of the incubation, the samples were acidified, extracted with ethyl acetate, dried down and resuspended in h.p.l.c., using a solvent system for prostaglandins (PGs), was subtracted from each experimental run in the same experiment. The remaining radioactivity constituted 0.14% of the original [3H]arachidonic acid added to each incubation tube. This was considered to have been the result of conversion of the radiolabelled arachidonic acid to prostanoids. In the absence of 10 mM-EDTA no conversion occurred, whereas in its presence peaks of radioactivity co-eluting with [3H]PGF-2 alpha and [3H]PGE-2 were seen. A third peak that eluted was either 15-keto metabolites of these PGs or PGD-2. These 3 peaks were always significantly above background, and usually did not differ from each other. No differences in amount of conversion could be related to incubation time. Addition of indomethacin (100 micrograms/ml) or radioinert arachidonic acid (10 micrograms/ml) inhibited production of [3H]PG, even in the presence of EDTA. Removal of calcium from the incubation medium was per se without effect. Addition of atropine (0.15 mM) or carbachol (0.15 mM) in the presence or absence of EDTA did not change the pattern of conversion of [3H]arachidonic acid to [3H]PGs. These experiments demonstrate that rabbit blastocysts have the capacity for de-novo synthesis of PGs from exogenous substrate, when utilization of endogenous substrate is inhibited. The extent of conversion observed may not be a true reflection of the capacity for conversion of endogenous substrate.
authors.affiliation: Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio 78284.
authors.forename: M J
authors.initials: MJ
authors.lastname: Harper
authors.forename: M A
authors.initials: MA
authors.lastname: Jones
authors.forename: C J
authors.initials: CJ
authors.lastname: Norris
authors.forename: D S
authors.initials: DS
authors.lastname: Woodard
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001285:Atropine / Q000378:metabolism; D001755:Blastocyst / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002217:Carbachol / Q000378:metabolism; D046508:Culture Techniques; D004492:Edetic Acid / Q000378:metabolism; D005260:Female; D007213:Indomethacin / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis*; D011817:Rabbits
chemical_list: D001095:Arachidonic Acids; D011453:Prostaglandins; D001285:Atropine; D002217:Carbachol; D004492:Edetic Acid; D002118:Calcium; D007213:Indomethacin